Literature DB >> 22887853

Anakinra for a refractory case of intermittent hydrarthrosis with a TRAPS-related gene mutation.

Mariano Andrés, Eliseo Pascual.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22887853     DOI： 10.1136/annrheumdis-2012-202087

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

Review 1.  An expanding role for interleukin-1 blockade from gout to cancer.

Authors:  Charles Anthony Dinarello
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

2.  The evaluation of gene polymorphisms associated with autoinflammatory syndrome in patients with palindromic rheumatism complicated by intermittent hydrarthrosis.

Authors:  Yumi Tani; Takayuki Kishi; Takako Miyamae; Manabu Kawamoto; Yasushi Kawaguchi; Atsuo Taniguchi; Hisashi Yamanaka
Journal:  Clin Rheumatol       Date:  2020-01-02       Impact factor: 2.980

Review 3.  Treating inflammation by blocking interleukin-1 in humans.

Authors:  Charles A Dinarello; Jos W M van der Meer
Journal:  Semin Immunol       Date:  2013-11-23       Impact factor: 11.130

Review 4.  Palindromic rheumatism as part of the rheumatoid arthritis continuum.

Authors:  Kulveer Mankia; Paul Emery
Journal:  Nat Rev Rheumatol       Date:  2019-10-08       Impact factor: 20.543

Review 5.  Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives.

Authors:  Giuseppe Lopalco; Luca Cantarini; Antonio Vitale; Florenzo Iannone; Maria Grazia Anelli; Laura Andreozzi; Giovanni Lapadula; Mauro Galeazzi; Donato Rigante
Journal:  Mediators Inflamm       Date:  2015-02-16       Impact factor: 4.711

Review 6.  Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.

Authors:  Peleg Rider; Yaron Carmi; Idan Cohen
Journal:  Int J Cell Biol       Date:  2016-12-19

7.  Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network.

Authors:  Carla Gaggiano; Donato Rigante; José Hernández-Rodríguez; Antonio Vitale; Maria Tarsia; Alessandra Soriano; Giuseppe Lopalco; Florenzo Iannone; Masen Abdel Jaber; Roberto Giacomelli; Ewa Wiȩsik-Szewczyk; Marco Cattalini; Micol Frassi; Matteo Piga; Gaafar Ragab; Jurgen Sota; Fiammetta Zunica; Alberto Floris; Vito Sabato; Mohamed Tharwat Hegazy; Olga Araújo; Laura Pelegrín; Alessandra Fabbiani; Alessandra Renieri; Salvatore Grosso; Claudia Fabiani; Bruno Frediani; Luca Cantarini
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-09-09       Impact factor: 5.346

Review 8.  Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.

Authors:  Caroline Vinit; Sophie Georgin-Lavialle; Aikaterini Theodoropoulou; Catherine Barbier; Alexandre Belot; Manel Mejbri; Pascal Pillet; Jana Pachlopnik; Sylvaine Poignant; Charlotte Rebelle; Andreas Woerner; Isabelle Koné-Paut; Véronique Hentgen
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.